310 results on '"Furey, Maura"'
Search Results
2. Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission From Depression
3. Antidepressant Effects of the Muscarinic Receptor Antagonist Scopolamine: Clinical and Preclinical Review
4. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder
5. Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants
6. Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults.
7. Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression
8. The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions
9. Beyond Sensory Images: Object-Based Representation in the Human Ventral Pathway
10. Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedonia
11. Distributed and Overlapping Representations of Faces and Objects in Ventral Temporal Cortex
12. Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
13. Cholinergic Enhancement and Increased Selectivity of Perceptual Processing during Working Memory
14. Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder
15. Translating depression biomarkers for improved targeted therapies
16. Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
17. Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
18. Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls
19. Baseline mood-state measures as predictors of antidepressant response to scopolamine
20. Neuroimaging Promises and Caveats
21. Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
22. Dissociation of Face-Selective Cortical Responses by Attention
23. Neuroimaging Promises and Caveats: Methodological Issues and Implications for Research in Psychological Disorders and Treatments
24. Altered connectivity among emotion-related brain regions during short-term memory in Alzheimer's disease
25. Neural basis of abnormal response to negative feedback in unmedicated mood disorders
26. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder
27. DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID-ACTING ANTIDEPRESSANTS
28. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
29. Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory
30. Pathogenesis of Depression: Clinical Studies
31. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial
32. Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission from Depression
33. Potential of Pretreatment Neural Activity in the Visual Cortex During Emotional Processing to Predict Treatment Response to Scopolamine in Major Depressive Disorder
34. Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention
35. Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials
36. Functional Brain Studies of the Neurometabolic Bases of Cognitive and Behavioral Changes in Alzheimer's Disease
37. Contributors
38. Pharmacological Modulation of Prefrontal Cortical Activity During a Working Memory Task in Young and Older Humans: A PET Study With Physostigmine
39. The Effects of Cholingeric Enhancement on Performance and BOLD signal in a Selective Attention Task: TH 72
40. Altered brain functional connectivity and impaired short-term memory in Alzheimerʼs disease
41. The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease
42. Association Between Brain Functional Failure and Dementia Severity in Alzheimer's Disease: Resting Versus Stimulation PET Study
43. jop-2018-3459-File012 – Supplemental material for Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants
44. Increasing Required Neural Response to Expose Abnormal Brain Function in Mild Versus Moderate or Severe Alzheimer's Disease: PET Study Using Parametric Visual Stimulation
45. Low Glucose Metabolism During Brain Stimulation in Older Down's Syndrome Subjects at Risk for Alzheimer's Disease Prior to Dementia
46. Association of Premorbid Intellectual Function With Cerebral Metabolism in Alzheimer's Disease: Implications for the Cognitive Reserve Hypothesis
47. Preferential Metabolic Involvement of Visual Cortical Areas in a Subtype of Alzheimer's Disease: Clinical Implications
48. Detailed Descriptions of the Behavioral Tasks from Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression
49. Investigation of Neurogranin Levels in Patients With Idiopathic Normal Pressure Hydrocephalus (iNPH) Using Two Independent Immunoassays
50. The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.